Seppo
Salminen
Senior Advisor, Nutrition and Food Research Center (NuFo)
Director, Nutrition and Food Research Center (NuFo)
MSc, MS, PhD
Links
Areas of expertise
Professor, Director
gut microbiota, probiotics and prebiotics, nutrition and food safety, EU regulations
Teaching
Functional Foods and EU legislation, Lactic acid biotechnology
Research
Food and health, intestinal microbiota, probiotics, prebiotics, functional foods, food legislation, health claims, novel foods
Publications
Scientific Opinion on the substantiation of health claims related to epigallocatechin gallate (EGCG) in combination with caffeine, and contribution to the maintenance or achievement of a normal body weight (ID 1800) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)
(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))Scientific Opinion on the substantiation of health claims related to water and maintenance of normal physical and cognitive functions (ID 1102, 1209, 1294, 1331), maintenance of normal thermoregulation (ID 1208) and “basic requirement of all living things” (ID 1207) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)
(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))Scientific Opinion on the substantiation of health claims related to caffeine and increased fat oxidation leading to a reduction in body fat mass (ID 735, 1484), increased energy expenditure leading to a reduction in body weight (ID 1487), increased alertness (ID 736, 1101, 1187, 1485, 1491, 2063, 2103) and increased attention (ID 736, 1485, 1491, 2375) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)
(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))Scientific Opinion on the substantiation of health claims related to “αS1-casein tryptic hydrolysate” and alleviation of psychological stress (ID 656, 1819, 4253) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)
(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))Scientific Opinion on the substantiation of health claims related to Lactobacillus johnsonii NCC 533 (La1) (CNCM I-1225) and improving immune defence against pathogenic gastro-intestinal microorganisms (ID 896), and protection of the skin from UV-induced damage (ID 900) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)
(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))Prebiotics (2011)
(Kirjan tai muun kokoomateoksen osa (B2))In Vitro Evaluation of Lactobacillus gasseri Strains of Infant Origin on Adhesion and Aggregation of Specific Pathogens (2011)
Journal of Food Protection
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))